Close Menu

Portugal has debuted a new cancer and neuroscience research center in Lisbon, reports the Associated Press. The facility was built by the Champalimaud Foundation, which began work four years ago. Portuguese businessman Antonio Champalimaud gave the foundation $688 million to complete the work and make the facility one of the best in the world, AP says. The foundation is now looking to recruit researchers from all over the world to work in the new center.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.